DiGeorge syndrome
DiGeorge Syndrome (22q11.2 Deletion Syndrome) | |
---|---|
Synonyms | Velocardiofacial syndrome (VCFS), Conotruncal anomaly face syndrome (CTAF), Autosomal dominant Opitz G/BBB syndrome, Cayler cardiofacial syndrome |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Cleft palate, Congenital heart defects, Hypocalcemia, Immune system disorders, Developmental delay, Learning disabilities, Speech disorders |
Complications | N/A |
Onset | Prenatal development or early childhood |
Duration | N/A |
Types | N/A |
Causes | 22q11.2 deletion |
Risks | N/A |
Diagnosis | Clinical examination, Fluorescence in situ hybridization (FISH), Comparative genomic hybridization (CGH) |
Differential diagnosis | N/A |
Prevention | N/A |
Treatment | Surgery, Speech therapy, Calcium supplementation, Early intervention therapy |
Medication | N/A |
Prognosis | N/A |
Frequency | 1 in 4,000 newborns |
Deaths | N/A |
DiGeorge Syndrome, also known as 22q11.2 Deletion Syndrome or Velocardiofacial Syndrome (VCFS), is a genetic disorder caused by the deletion of a small portion of chromosome 22 at position 22q11.2. This syndrome affects multiple systems in the body and is associated with cleft palate, congenital heart defects, immune system dysfunction, hypocalcemia, developmental delays, and learning disabilities. It is one of the most common microdeletion syndromes, occurring in approximately 1 in 4,000 live births, though the actual number may be higher due to undiagnosed cases.
Signs and Symptoms
The symptoms of DiGeorge Syndrome vary widely, even among affected family members. Some individuals may have mild symptoms, while others experience severe complications.
Craniofacial Features
- Cleft palate or other palatal abnormalities
- Characteristic facial features, including:
- Elongated face
- Almond-shaped eyes
- Wide nose bridge
- Small ears
- Underdeveloped chin (micrognathia)
Cardiovascular Abnormalities
- Congenital heart defects, particularly affecting the conotruncal region of the heart:
- Tetralogy of Fallot
- Interrupted aortic arch
- Ventricular septal defect
- Truncus arteriosus
Immune System Dysfunction
- Thymic hypoplasia (underdeveloped or missing thymus gland) leading to:
- Frequent infections
- Increased susceptibility to bacterial and viral infections
- Immune system disorders similar to severe combined immunodeficiency (SCID)
Endocrine and Metabolic Issues
- Hypocalcemia (low calcium levels) due to hypoparathyroidism
- Can result in seizures, muscle spasms, and neuromuscular irritability
- Abnormal kidney structure or function
Developmental and Neurological Effects
- Learning disabilities (affects ~90% of individuals)
- Speech disorders (affects ~75%)
- Delayed motor and cognitive development
- Non-verbal learning disability
- Verbal IQ scores tend to be significantly higher than performance IQ scores
- Autism spectrum disorder-like social communication difficulties
- Increased risk of psychiatric disorders, including:
- Depression
- Anxiety
- Schizophrenia (affects ~25-30% of adults with 22q11.2 deletion)
Genetics and Pathophysiology
DiGeorge Syndrome is caused by a deletion on chromosome 22 at position 22q11.2, which results in the loss of approximately 30 genes. Two key genes associated with the syndrome are:
- TBX1 – A transcription factor essential for the development of the heart, thymus, and palate.
- COMT – Involved in dopamine metabolism and linked to cognitive function and psychiatric symptoms.
Most cases (93%) occur sporadically due to a de novo deletion, meaning neither parent carries the deletion. However, in 7-10% of cases, the syndrome is inherited in an autosomal dominant manner, meaning an affected parent has a 50% chance of passing the deletion to their offspring.
Diagnosis
Clinical Evaluation
DiGeorge Syndrome is suspected in individuals with a combination of cardiac, craniofacial, immunological, and endocrine abnormalities. A full medical history and clinical examination are performed to assess characteristic signs.
Genetic Testing
The deletion in chromosome 22q11.2 can be detected using:
- Fluorescence in situ hybridization (FISH) – Standard diagnostic test (~95% detection rate)
- Comparative genomic hybridization (CGH) – More sensitive for identifying smaller deletions
- Multiplex ligation-dependent probe amplification (MLPA) – Can detect smaller submicroscopic deletions
Treatment and Management
There is no cure for DiGeorge Syndrome, but treatment focuses on managing individual symptoms.
Cardiac Treatment
- Congenital heart defects are often surgically corrected in infancy.
Endocrine and Metabolic Treatment
- Hypocalcemia is treated with calcium supplementation and vitamin D to prevent seizures and muscle spasms.
- Thyroid function monitoring is necessary as thyroid abnormalities may be present.
Immune System Management
- Infants with severe immunodeficiency may require thymus transplantation or bone marrow transplantation.
- Antibiotic prophylaxis may be necessary for those with recurrent infections.
- Live vaccines are contraindicated in individuals with severe T-cell deficiency.
Speech and Developmental Therapy
- Speech therapy for palatal dysfunction and articulation difficulties.
- Early intervention programs for learning disabilities and developmental delays.
Psychiatric and Neurological Support
- Individuals at risk for psychiatric conditions may require counseling or medication.
- Cognitive behavioral therapy (CBT) for anxiety and depression.
- Special education programs tailored to support learning differences.
Inheritance and Genetic Counseling
DiGeorge Syndrome is caused by a spontaneous deletion in most cases, meaning the risk of recurrence in future siblings is low. However, if a parent carries the deletion, each child has a 50% chance of inheriting the syndrome.
Genetic counseling is recommended for:
- Parents of a child with the syndrome.
- Adults diagnosed with the syndrome who are planning a family.
Prognosis
The lifespan and quality of life of individuals with DiGeorge Syndrome depend on the severity of their symptoms. With early intervention, medical management, and supportive care, many individuals lead productive lives.
See Also
External Links
- Genetics Home Reference - 22q11.2 Deletion Syndrome
- National Center for Biotechnology Information (NCBI) - DiGeorge Syndrome
NIH genetic and rare disease info
DiGeorge syndrome is a rare disease.
Rare and genetic diseases | ||||||
---|---|---|---|---|---|---|
Rare diseases - DiGeorge syndrome
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Admin, Prab R. Tumpati, MD